Skip to main content
Top
Published in: BMC Gastroenterology 1/2010

Open Access 01-12-2010 | Research article

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Authors: Chantal A Rivera, LaTausha Gaskin, Monique Allman, Jia Pang, Kristen Brady, Patrick Adegboyega, Kevin Pruitt

Published in: BMC Gastroenterology | Issue 1/2010

Login to get access

Abstract

Background

Previously we reported that mice deficient in toll-like receptor 4 (TLR-4) signalling were protected from diet-induced non-alcoholic steatohepatitis (NASH). Another member of the toll-like receptor family, TLR-2, has been shown to play a role in lipid trafficking via uptake of diacylated lipoproteins. However, a role for TLR-2 in NASH has not been elucidated. The objectives of the current study were to examine the influence of dietary fat quality and TLR-2 on NASH pathogenesis.

Methods

Steatohepatitis was induced in male Db, C57BL/6 and TLR-2-/- mice by feeding an L-amino acid-defined diet that was deficient in methionine and choline (MCDD). Mice fed the base diet supplemented with methionine and choline (control diet; CD) were used as controls. To determine the role of fat quality, MCDD was enriched with polyunsaturated corn oil (PUFA) or coconut oil that is comprised mostly of saturated fat (SAFA); the total amount of each fat was 112.9 g/kg of diet. After 8 weeks of feeding CD or MCDD, hepatic steatosis, inflammation and necrosis were evaluated in histological sections. Total RNA was extracted from frozen liver samples and mRNA expression of TNFα, collagen α1, IL-10, peroxisome proliferator-activated receptor-γ (PPAR-γ), TLR-4, and CD14, was analyzed via real-time PCR. Protein levels of TLR-2 were analyzed by western blot.

Results

Panlobular macrovessicular steatosis and diffuse leukocyte infiltration were noted in PUFA-fed Db mice. Histological scores demonstrated significantly less steatosis, inflammation and necrosis in SAFA-fed mice of all mouse strains. However, compared to wild type mice, hepatocellular damage was notably more severe in TLR-2-/- mice. Consistent with histological findings, mRNA expression of TNFα was elevated by approximately 3-fold in TLR-2-/- mice; PPAR-γ expression was blunted in this strain compared to wild type. Expression of the matrix protein collagen αI was also significantly higher in TLR-2-/- mice, indicating a pro-fibrogenic state. Sensitivity to steatohepatitis due to dietary fat or TLR-2 deficiency correlated significantly with alterations in the expression of TLR-4 as well as the co-receptor CD-14.

Conclusions

Our findings suggest that dietary saturated fat plays a protective role against MCDD-induced steatohepatitis, whereas TLR-2 deficiency exacerbated NASH. The mechanism underlying the response to dietary fat and TLR-2 likely involves altered signalling via the TLR-4 pathway.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tarantino G, Saldalamacchia G, Conca P, Arena A: Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007, 22: 293-303. 10.1111/j.1440-1746.2007.04824.x.CrossRefPubMed Tarantino G, Saldalamacchia G, Conca P, Arena A: Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007, 22: 293-303. 10.1111/j.1440-1746.2007.04824.x.CrossRefPubMed
2.
go back to reference Dall TM, Fulgoni VL, Zhang Y, Reimers KJ, Packard PT, Astwood JD: Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot. 2009, 23: 412-422. 10.4278/ajhp.080930-QUAN-226.CrossRefPubMed Dall TM, Fulgoni VL, Zhang Y, Reimers KJ, Packard PT, Astwood JD: Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot. 2009, 23: 412-422. 10.4278/ajhp.080930-QUAN-226.CrossRefPubMed
3.
go back to reference Lopez S, Bermudez B, Pacheco YM, Villar J, Abia R, Muriana FJ: Distinctive postprandial modulation of {beta} cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr. 2008, 88: 638-644.PubMed Lopez S, Bermudez B, Pacheco YM, Villar J, Abia R, Muriana FJ: Distinctive postprandial modulation of {beta} cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr. 2008, 88: 638-644.PubMed
4.
go back to reference Lichtenstein AH, Kennedy E, Barrier P, Danford D, Ernst ND, Grundy SM, Leveille GA, Van HL, Williams CL, Booth SL: Dietary fat consumption and health. Nutr Rev. 1998, 56: S3-19. 10.1111/j.1753-4887.1998.tb01728.x.CrossRefPubMed Lichtenstein AH, Kennedy E, Barrier P, Danford D, Ernst ND, Grundy SM, Leveille GA, Van HL, Williams CL, Booth SL: Dietary fat consumption and health. Nutr Rev. 1998, 56: S3-19. 10.1111/j.1753-4887.1998.tb01728.x.CrossRefPubMed
5.
go back to reference Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW: Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol. 2008, 28: 1982-1988. 10.1161/ATVBAHA.108.169722.CrossRefPubMedPubMedCentral Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW: Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol. 2008, 28: 1982-1988. 10.1161/ATVBAHA.108.169722.CrossRefPubMedPubMedCentral
6.
go back to reference West NA, Hamman RF, Mayer-Davis EJ, D'Agostino RB, Marcovina SM, Liese AD, Zeitler PS, Daniels SR, Dabelea D: Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care. 2009, 32: 175-180. 10.2337/dc08-1442.CrossRefPubMedPubMedCentral West NA, Hamman RF, Mayer-Davis EJ, D'Agostino RB, Marcovina SM, Liese AD, Zeitler PS, Daniels SR, Dabelea D: Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care. 2009, 32: 175-180. 10.2337/dc08-1442.CrossRefPubMedPubMedCentral
7.
go back to reference Musso G, Gambino R, De MF, Cassader M, Rizzetto M, Durazzo M, Faga E, Silli B, Pagano G: Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatol. 2003, 37: 909-916. 10.1053/jhep.2003.50132.CrossRef Musso G, Gambino R, De MF, Cassader M, Rizzetto M, Durazzo M, Faga E, Silli B, Pagano G: Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatol. 2003, 37: 909-916. 10.1053/jhep.2003.50132.CrossRef
8.
go back to reference Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH: Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2003, 44: 479-486. 10.1194/jlr.M200361-JLR200.CrossRefPubMed Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH: Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2003, 44: 479-486. 10.1194/jlr.M200361-JLR200.CrossRefPubMed
9.
go back to reference Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z: EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int. 2005, 67: 867-874. 10.1111/j.1523-1755.2005.00151.x.CrossRefPubMed Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z: EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int. 2005, 67: 867-874. 10.1111/j.1523-1755.2005.00151.x.CrossRefPubMed
10.
go back to reference Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH: Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem. 2003, 278: 37041-37051. 10.1074/jbc.M305213200.CrossRefPubMed Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH: Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem. 2003, 278: 37041-37051. 10.1074/jbc.M305213200.CrossRefPubMed
11.
go back to reference Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH: Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol. 2005, 174: 5390-5397.CrossRefPubMed Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH: Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol. 2005, 174: 5390-5397.CrossRefPubMed
12.
go back to reference Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C: Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res. 2005, 126: 121-129. 10.1016/j.jss.2004.12.023.CrossRefPubMed Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C: Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res. 2005, 126: 121-129. 10.1016/j.jss.2004.12.023.CrossRefPubMed
13.
go back to reference Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F: Activation of NF-{kappa}B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation. Arterioscler Thromb Vasc Biol. 2009, 29: 1370-1375. 10.1161/ATVBAHA.109.188813.CrossRefPubMedPubMedCentral Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, Kim F: Activation of NF-{kappa}B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation. Arterioscler Thromb Vasc Biol. 2009, 29: 1370-1375. 10.1161/ATVBAHA.109.188813.CrossRefPubMedPubMedCentral
14.
go back to reference Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M: Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. 2007, 47: 571-579. 10.1016/j.jhep.2007.04.019.CrossRefPubMedPubMedCentral Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M: Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. 2007, 47: 571-579. 10.1016/j.jhep.2007.04.019.CrossRefPubMedPubMedCentral
15.
go back to reference Takeuchi O, Sato S, horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S: Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol. 2002, 169: 10-14.CrossRefPubMed Takeuchi O, Sato S, horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S: Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol. 2002, 169: 10-14.CrossRefPubMed
16.
go back to reference Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, Beutler B: CD36 is a sensor of diacylglycerides. Nature. 2005, 433: 523-527. 10.1038/nature03253.CrossRefPubMed Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, Beutler B: CD36 is a sensor of diacylglycerides. Nature. 2005, 433: 523-527. 10.1038/nature03253.CrossRefPubMed
17.
go back to reference McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC: Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatol. 2004, 40: 386-393. 10.1002/hep.20302.CrossRef McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC: Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatol. 2004, 40: 386-393. 10.1002/hep.20302.CrossRef
18.
go back to reference Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall PL: Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol. 2003, 18: 1272-1282. 10.1046/j.1440-1746.2003.03198.x.CrossRefPubMed Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall PL: Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol. 2003, 18: 1272-1282. 10.1046/j.1440-1746.2003.03198.x.CrossRefPubMed
19.
go back to reference Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF: Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G1035-G1043. 10.1152/ajpgi.00199.2004.CrossRefPubMed Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF: Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G1035-G1043. 10.1152/ajpgi.00199.2004.CrossRefPubMed
20.
go back to reference Rivera CA, Abrams SH, Tcharmtchi MH, Allman M, Ziba TT, Finegold MJ, Smith CW: Feeding a corn oil/sucrose-enriched diet enhances steatohepatitis in sedentary rats. Am J Physiol Gastrointest Liver Physiol. 2006, 290: G386-G393. 10.1152/ajpgi.00229.2005.CrossRefPubMed Rivera CA, Abrams SH, Tcharmtchi MH, Allman M, Ziba TT, Finegold MJ, Smith CW: Feeding a corn oil/sucrose-enriched diet enhances steatohepatitis in sedentary rats. Am J Physiol Gastrointest Liver Physiol. 2006, 290: G386-G393. 10.1152/ajpgi.00229.2005.CrossRefPubMed
21.
go back to reference Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P: Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995, 75: 71B-74B. 10.1016/0002-9149(95)80017-M.CrossRefPubMed Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P: Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995, 75: 71B-74B. 10.1016/0002-9149(95)80017-M.CrossRefPubMed
22.
go back to reference Keogh JB, Grieger JA, Noakes M, Clifton PM: Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol. 2005, 25: 1274-1279. 10.1161/01.ATV.0000163185.28245.a1.CrossRefPubMed Keogh JB, Grieger JA, Noakes M, Clifton PM: Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol. 2005, 25: 1274-1279. 10.1161/01.ATV.0000163185.28245.a1.CrossRefPubMed
23.
go back to reference Nanji AA, French SW: Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci. 1989, 44: 223-227. 10.1016/0024-3205(89)90599-7.CrossRefPubMed Nanji AA, French SW: Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci. 1989, 44: 223-227. 10.1016/0024-3205(89)90599-7.CrossRefPubMed
24.
go back to reference Nanji AA, Mendenhall CL, French SW: Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res. 1989, 13: 15-19. 10.1111/j.1530-0277.1989.tb00276.x.CrossRefPubMed Nanji AA, Mendenhall CL, French SW: Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res. 1989, 13: 15-19. 10.1111/j.1530-0277.1989.tb00276.x.CrossRefPubMed
25.
go back to reference Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR, Dannenberg AJ: Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatol. 1997, 26: 1538-1545. 10.1002/hep.510260622.CrossRef Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR, Dannenberg AJ: Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatol. 1997, 26: 1538-1545. 10.1002/hep.510260622.CrossRef
26.
go back to reference Nanji AA, French SW: Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res. 1986, 10: 271-273. 10.1111/j.1530-0277.1986.tb05088.x.CrossRefPubMed Nanji AA, French SW: Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res. 1986, 10: 271-273. 10.1111/j.1530-0277.1986.tb05088.x.CrossRefPubMed
27.
go back to reference You M, Considine RV, Leone TC, Kelly DP, Crabb DW: Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatol. 2005, 42: 568-577. 10.1002/hep.20821.CrossRef You M, Considine RV, Leone TC, Kelly DP, Crabb DW: Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatol. 2005, 42: 568-577. 10.1002/hep.20821.CrossRef
28.
go back to reference Szabo G, Velayudham A, Romics L, Mandrekar P: Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res. 2005, 29: 140S-145S. 10.1097/01.alc.0000189287.83544.33.CrossRefPubMed Szabo G, Velayudham A, Romics L, Mandrekar P: Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res. 2005, 29: 140S-145S. 10.1097/01.alc.0000189287.83544.33.CrossRefPubMed
29.
go back to reference Brun P, Castagliuolo I, Di LV, Buda A, Pinzani M, Palu' G, Martines D: Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2006, 22: 293-303. Brun P, Castagliuolo I, Di LV, Buda A, Pinzani M, Palu' G, Martines D: Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2006, 22: 293-303.
30.
go back to reference Abergel A, Sapin V, Dif N, Chassard C, Darcha C, Marcand-Sauvant J, Gaillard-Martinie B, Rock E, Dechelotte P, Sauvant P: Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig Dis Sci. 2006, 51: 986-995. 10.1007/s10620-005-9031-y.CrossRefPubMed Abergel A, Sapin V, Dif N, Chassard C, Darcha C, Marcand-Sauvant J, Gaillard-Martinie B, Rock E, Dechelotte P, Sauvant P: Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig Dis Sci. 2006, 51: 986-995. 10.1007/s10620-005-9031-y.CrossRefPubMed
31.
go back to reference Allman M, Gaskin L, Rivera CA: CCl4-induced hepatic injury in mice fed a wstern diet is associated with blunted healing. J Gastroenterol Hepatol. 2010, 25: 635-643. 10.1111/j.1440-1746.2009.06112.x.CrossRefPubMedPubMedCentral Allman M, Gaskin L, Rivera CA: CCl4-induced hepatic injury in mice fed a wstern diet is associated with blunted healing. J Gastroenterol Hepatol. 2010, 25: 635-643. 10.1111/j.1440-1746.2009.06112.x.CrossRefPubMedPubMedCentral
Metadata
Title
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Authors
Chantal A Rivera
LaTausha Gaskin
Monique Allman
Jia Pang
Kristen Brady
Patrick Adegboyega
Kevin Pruitt
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2010
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-10-52

Other articles of this Issue 1/2010

BMC Gastroenterology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine